tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Want to see EDIT full AI Analyst Report?

Compare Editas Medicine (EDIT) vs. Competitors

3,587 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$3.28
$414.67M
-3.61
1.86%
4 Buy
1 Hold
1 Sell
Moderate Buy
Cellectis SA
$3.42
$220.73M
-4.67
-36.68%
1 Buy
0 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$6.69
$262.48M
-4.46
-15.99%
6 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$3.01
$53.88M
-0.96
-82.61%
2 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$24.01
$1.32B
-0.07
-33.68%
4 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$1.65
$136.15M
-1.18
-28.33%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.74
0.07
2.62%
CLLS
Cellectis SA
1.83
-1.16
-38.80%
FHTX
Foghorn Therapeutics
4.36
-0.63
-12.63%
ELTX
Elicio Therapeutics
2.00
-8.08
-80.16%
VOR
Vor Biopharma
23.08
-8.92
-27.88%
CRBU
Caribou Biosciences
1.29
-0.54
-29.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts